Brief: Hydration Pharmaceuticals Says Unaudited Net Sales In Q2 FY2023 Of $1.7 Mln
15/06/2023 02:17
June 15 (Reuters) - Hydration Pharmaceuticals Co Ltd
HPC.AX :
* UNAUDITED NET SALES IN Q2 FY2023 OF US$1.7M, A 31%
INCREASE
Source text for Eikon: ID:nASX45CvdY
Further company coverage: HPC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hydration Pharmaceuticals
See all newsBrief: Hydration Pharmaceuticals Launches Pro Rata Entitlement Offer To Raise Up To A$1.43 MLN
Australia's Hydration Pharmaceuticals soars on upbeat monthly sales
Australia's Hydration Pharmaceuticals soars 144% on asset sale to US co
Brief: Hydration Pharmaceuticals Announces Divesture Of Hydralyte's Non-US Assets
Brief: Hydration Pharmaceuticals Says Adem Karafili Appointed Non-Executive Chairman